buprenorphine

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has announced an investigator-initiated study to assess the perioperative use of Dsuvia (sufentanil sublingual tablet) for same-day surgical procedures in patients on buprenorphine therapy for opioid-use disorder or chronic pain...

Last year wasn't incredibly receptive to the IPO market, but prospects appear to be brighter for the current year, as an Ernst & Young report predicts that the United States will lead a recovery in global IPO activity in 2017. The report said there is now a pipeline of more than 130 companies...

The Wall Street Journal recently reported President Obama’s administration will loosen its strict controls on a medication called buprenorphine, which is used to treat addiction to heroin and other opioid-based drugs. The Department of Health and Human Services up until now only allowed...